Avistone Announces Phase II Results for Vebreltinib, a c-Met Tyrosine Kinase Inhibitor (TKI) at the European Society for Clinical Oncology (ESMO) Congress
BEIJING–(BUSINESS WIRE)–Avistone Biotechnology Co., Ltd. (“Avistone” or “the Company”), a clinical-stage biotechnology company focused on precision... Read more.
Quectel Expands Its IoT Antenna Portfolio With Six New 4G and 5G Antennas
VANCOUVER, British Columbia–(BUSINESS WIRE)–Quectel, a global IoT solutions provider, has unveiled six new antennas designed to provide robust connectivity... Read more.
Datopotamab deruxtecan improved progression-free survival vs. chemotherapy in patients with previously treated non-small cell lung cancer in TROPION-Lung01 Phase III trial
AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan reduced the risk of disease progression or death by 25% in overall population and by 37% in patients with... Read more.
SIMO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Silicon Motion Technology Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK–(BUSINESS WIRE)–$SIMO #classaction–Attorney Advertising– Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm,... Read more.
ENHERTU® (fam-trastuzumab deruxtecan-nxki) Demonstrated Clinically Meaningful Survival Across Multiple HER2-Expressing Advanced Solid Tumors in DESTINY-PanTumor02 Phase II Trial
AstraZeneca and Daiichi Sankyo’s ENHERTU showed a median progression-free survival of 6.9 months and median overall survival of 13.4 months in the overall trial... Read more.
ENHERTU® Demonstrated Clinically Meaningful Survival Across Multiple HER2 Expressing Advanced Solid Tumors in DESTINY-PanTumor02 Phase 2 Trial
Daiichi Sankyo and AstraZeneca’s ENHERTU showed a median progression-free survival of 6.9 months and median overall survival of 13.4 months in the overall trial... Read more.
Wandke Consulting Rebrands as Wandke Accessibility
Innovative disability-owned agency specializing in helping companies create accessible services, platforms, and environments unveils new website logo and client... Read more.
Global ADC (Antibody Drug Conjugates) Market Research Report 2023-2035: Focus on ADC Linker and ADC Conjugation Technologies – Over 420 ADCs are Currently Being Evaluated – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “ADC Technology Market: Focus on ADC Linker and ADC Conjugation Technologies (2nd Edition) – Distribution by Generation... Read more.
Ryan Recognized as a Best Workplace in North Texas by the Dallas Business Journal for 13th Consecutive Year
DALLAS–(BUSINESS WIRE)–Ryan, a leading global tax services and software provider, has recently been named to the 2023 Dallas Business Journal’s Best... Read more.
At AES 2023, Taqtile Previews Spatial Computing Work-Instruction Platform on HTC VIVE XR Elite
Taqtile to Leverage Color Passthrough Capabilities of Headset in Manifest Demonstration at HTC VIVE Booth HOUSTON–(BUSINESS WIRE)–Taqtile, Inc., will... Read more.